about
Future of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology.Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral ironA Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyIron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy.Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials.Iron deficiency anemia in patients with inflammatory bowel disease.Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.Ferric carboxymaltose for the treatment of iron-deficiency anemia. [corrected].State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease.Nanoparticles and the cardiovascular system: a critical review.Magnetic nanoparticles for oligodendrocyte precursor cell transplantation therapies: progress and challengesSingle-dose intravenous iron for iron deficiency: a new paradigm.Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose.Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation.Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer.The safety of available treatment options for iron-deficiency anemia.
P2860
Q30360777-3FDF2490-3528-4C6C-84C5-48A24FCC80A1Q34470847-57DB551E-15F0-40F7-A551-69F26DBD449BQ34477467-08C2CBCB-8166-4391-BC6C-F408D4324C11Q36076079-145408CE-2873-46F3-9FF6-31C551C5A6BAQ36241297-3DD0AA44-BA61-4FA0-BA47-214DB9C551B5Q36918762-B061E30A-B3F5-48F3-AE81-5D9E85BB0D68Q37543916-86DB0D14-E778-4CAE-A1D5-BEB649B4A10EQ37993131-5B2C34DE-2949-4808-B430-9BA2AC4D17BEQ38037260-A4A08A50-67AA-42B5-82DC-314750DCB9DDQ38087984-49922805-8A1D-42D8-98AC-571BFE8E8381Q38521746-D0F51E12-7819-4A8D-9F85-86CD11EAF8A6Q39027699-6AEDBD22-84ED-47A4-B5D4-1F436A74E0CFQ41173473-B01E9032-2EF1-40AD-A8E1-B4C332C67DC3Q41897456-AAA7EAC2-54FC-4621-9E22-AC85DE0EE5F5Q42276525-41AC3394-1F3B-43E0-9323-1B3F95B30AC0Q47150560-A05A5DB7-AC1B-409D-A0AC-4D4D51404DC1Q48548255-0F4FCBB2-3086-4E4C-8CD3-DC64070D5A5D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Ferumoxytol for the treatment of iron deficiency.
@ast
Ferumoxytol for the treatment of iron deficiency.
@en
type
label
Ferumoxytol for the treatment of iron deficiency.
@ast
Ferumoxytol for the treatment of iron deficiency.
@en
prefLabel
Ferumoxytol for the treatment of iron deficiency.
@ast
Ferumoxytol for the treatment of iron deficiency.
@en
P2860
P356
P1476
Ferumoxytol for the treatment of iron deficiency.
@en
P2093
Michael Auerbach
P2860
P304
P356
10.1586/EHM.11.31
P577
2011-08-01T00:00:00Z